Sorafenib Plus 5-Azacitidine Initial Therapy of Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MS) With FLT3-ITD Mutation
PHASE2
The goal of this clinical research study is to learn if 5-azacitidine and s...
It is a prospective, non-interventional, open-label study, in order to obse...
Status
Unknown
Location
The First Affiliated Hospital of Soochow University
Start Date
2014-06
Trial ID
NCT02156297
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
PHASE1
Ziftomenib is an investigational drug in development for the treatment of p...
Comparison of the Efficacy and Safety of Venetoclax in Combination With 3 Days Decitabine (DEC3-VEN) vs. Venetoclax in Combination With Azacitidine (VIALE-A) in the Treatment of Elderly Patients or Unfit, New-diagnosis Acute Myeloid Leukemia Patients
PHASE3
Combining the results of previous studies and based on the clinical practic...
Status
Unknown
Location
The Second Affiliated Hospital of Kunming Medical University.